関連する実験動画
Updated: Jan 31, 2026
03:42
Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
Published on: March 29, 2024
2.1K
若者 の 中 で 放出 分数 が 保存 さ れ て いる 心臓 衰弱
Jasper Tromp1,2,3, Michael R MacDonald4, Wan Ting Tay2
1University Medical Center Groningen, Department of Cardiology, the Netherlands (J.T., C.S.P.L.).
Circulation
|December 20, 2018
まとめ
HFpEF (保存されたエジェクション分数を持つ心不全) は,しばしば肥満によって引き起こされる,若い成人に影響を及ぼします. 高齢患者より生活の質が優れているにもかかわらず,若いHFpEF患者は,心不全のない患者と比較して著しく悪い結果に直面します.
科学分野:
- 心臓病科
- ゲロントロジー
- 公衆衛生
背景:
- 発射分数保存 (HFpEF) による心不全は,通常高齢者に見られる.
- 若い人群におけるHFpEFの特徴とアウトカムはまだ十分に研究されていない.
- この研究では,65歳未満の個体でHFpEFを調査しています.
研究 の 目的:
- 若い患者のグループにおけるHFpEFの特徴
- HFpEF患者の異なる年齢層における臨床的および心声学的特徴,生活の質,およびアウトカムを比較する.
- 年齢と性別を合わせた対照群と非常に若いHFpEF患者と比較する.
主な方法:
- アジアの11地域から1203人のHFpEF患者 (エジェクション分数 ≥50%) の予期登録.
- 年齢分類:非常に若い (<55歳),若い (55歳から64歳),高齢者 (65歳から74歳),高齢者 (≥75歳).
- 臨床データ,心声検査,生活の質,1年間のアウトカムを比較し,非常に若いHFpEFと対照群を比較した.
主要な成果:
- HFpEF患者の37%は65歳未満で,このグループは男性優勢で,肥満率が高かった (36%対16%),腎機能低下,心房細動,高血圧が少ない.
- HFpEFの非常に若い患者と高齢者の間では,左心室の充填圧と高縮率が類似していました.
- 非常に若いHFpEF患者は,高齢のHFpEF患者 (21%),よりよい生活の質と1年での死亡/入院率が低いが,対照群より3倍高い死亡率を示した.
結論:
- 若いHFpEF患者は,高齢の患者と同様の不良心改造を示します.
- 若者におけるHFpEFは,心不全のない対照群と比較して,著しく悪い結果と関連しています.
- 肥満は若者のHFpEFに大きく寄与する可能性があります.
関連する概念動画
01:29Heart Failure II: Pathophysiology
920
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
920
01:17Pathophysiology of Heart Failure
3.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.6K
01:27Heart Failure I: Introduction
882
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
882
01:22Heart Failure VI: Adjunct Therapies
336
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
336
01:22Heart Failure Drugs: Diuretics
966
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
966
01:30Heart Failure V: Medical Management
312
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
312